News

Qilu' s Sales Ranked as No. 3 in 2009

ABOUT US

News

Qilu' s Sales Ranked as No. 3 in 2009

Release time：

2010-06-17

China Chemical and Pharmaceutical Industry Association published Top 100 Sales in 2009 of pharmaceutical companies and Roche Shanghai, Pfizer Dalian and Shandong Qilu with the growing rate 17.2%, 27.2% and 26.6% respectively are in the first three places, reported by Medical Economy on May 31.

Among the Top 10 best sales in hospital consumption value, Roche Shanghai ranked No.1 with the sales of 1.38 billion RMB, Pfizer Dalian is in the sencond place and Qilu ranked No.3 with the sales of 1.19 billion RMB.

Qilu held honoring ceremony for excellent young staff

Qilu Organized Tree-planting Activity

Related News

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list